Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
Leukemia
|
January 30, 2019
Is lenalidomide the standard-of-care after an autotransplant for plasma cell myeloma?
Giovanni Barosi, Robert Peter Gale
Leukemia
|
March 4, 2023
Myelofibrosis-type megakaryocyte dysplasia (MTMD) as a distinct category of BCR::ABL-negative myeloproliferative neoplasms. Challenges and perspectives
Giovanni Barosi, Vittorio Rosti, Robert Peter Gale
Leukemia
|
June 12, 2021
NK-/T-cell lymphomas
Hua Wang, Bi-Bo Fu, Robert Peter Gale, et al.
Leukemia
|
August 20, 2021
Is the Sokal or EUTOS long-term survival (ELTS) score a better predictor of responses and outcomes in persons with chronic myeloid leukemia receiving tyrosine-kinase inhibitors?
Xiao-Shuai Zhang, Robert Peter Gale, Xiao-Jun Huang, et al.
Leukemia
|
December 5, 2024
Is there really an accelerated phase of chronic myeloid leukaemia at presentation?
Sen Yang, Xiaoshuai Zhang, Robert Peter Gale, et al.
Leukemia
|
January 10, 2020
Recent drug approvals for newly diagnosed acute myeloid leukemia: gifts or a Trojan horse?
Elihu Estey, Judith E Karp, Ashkan Emadi, et al.
Leukemia
|
May 13, 2022
Co-variates associated with outcomes of tyrosine kinase-inhibitor therapy in persons with chronic myeloid leukaemia initially presenting in accelerated phase
Sen Yang, Xiao-Shuai Zhang, Robert Peter Gale, et al.
Leukemia
|
February 23, 2022
A predictive scoring system for therapy-failure in persons with chronic myeloid leukemia receiving initial imatinib therapy
Xiao-Shuai Zhang, Robert Peter Gale, Mei-Jie Zhang, et al.
Leukemia
|
May 7, 2020
Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis
Huan Li, Chongxiang Chen, Fang Hu, et al.
Leukemia
|
May 15, 2021
JAK-inhibitors for coronavirus disease-2019 (COVID-19): a meta-analysis
Chong-Xiang Chen, Jiao-Jiao Wang, Huan Li, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
Leukemia
|
January 30, 2019
Is lenalidomide the standard-of-care after an autotransplant for plasma cell myeloma?
Giovanni Barosi, Robert Peter Gale
Leukemia
|
March 4, 2023
Myelofibrosis-type megakaryocyte dysplasia (MTMD) as a distinct category of BCR::ABL-negative myeloproliferative neoplasms. Challenges and perspectives
Giovanni Barosi, Vittorio Rosti, Robert Peter Gale
Leukemia
|
June 12, 2021
NK-/T-cell lymphomas
Hua Wang, Bi-Bo Fu, Robert Peter Gale, et al.
Leukemia
|
August 20, 2021
Is the Sokal or EUTOS long-term survival (ELTS) score a better predictor of responses and outcomes in persons with chronic myeloid leukemia receiving tyrosine-kinase inhibitors?
Xiao-Shuai Zhang, Robert Peter Gale, Xiao-Jun Huang, et al.
Leukemia
|
December 5, 2024
Is there really an accelerated phase of chronic myeloid leukaemia at presentation?
Sen Yang, Xiaoshuai Zhang, Robert Peter Gale, et al.
Leukemia
|
January 10, 2020
Recent drug approvals for newly diagnosed acute myeloid leukemia: gifts or a Trojan horse?
Elihu Estey, Judith E Karp, Ashkan Emadi, et al.
Leukemia
|
May 13, 2022
Co-variates associated with outcomes of tyrosine kinase-inhibitor therapy in persons with chronic myeloid leukaemia initially presenting in accelerated phase
Sen Yang, Xiao-Shuai Zhang, Robert Peter Gale, et al.
Leukemia
|
February 23, 2022
A predictive scoring system for therapy-failure in persons with chronic myeloid leukemia receiving initial imatinib therapy
Xiao-Shuai Zhang, Robert Peter Gale, Mei-Jie Zhang, et al.
Leukemia
|
May 7, 2020
Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis
Huan Li, Chongxiang Chen, Fang Hu, et al.
Leukemia
|
May 15, 2021
JAK-inhibitors for coronavirus disease-2019 (COVID-19): a meta-analysis
Chong-Xiang Chen, Jiao-Jiao Wang, Huan Li, et al.
Page
of 4